215
Participants
Start Date
September 30, 2015
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
BAY2757556 (Larotrectinib, Vitrakvi)
Larotrectinib will be administered orally as capsule or liquid solution at a dose of 100 mg twice daily in continuing 28-days cycles.
University of Washington, Seattle
Tri-Service General Hospital, Taipei
IRCCS Istituti Fisioterapici Ospitalieri - IFO, Rome
Royal Darwin Hospital, Tiwi
Institut Jules Bordet/Jules Bordet Instituut, Brussels
Rigshospitalet - Kræftbehandling, Copenhagen OE
Macquarie University Hospital, Sydney
Seoul National University Hospital, Seoul
St John of God Healthcare, Subiaco
Health Ministry Of Türkiye Republic Ankara Bilkent City Hospital, Ankara
Institut Catala D'oncologia - Oncologia, Barcelona
Memorial Sloan Kettering Cancer Center New York - Main Campus, New York
Charité Comprehensive Cancer Center (CCCC), Berlin
Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
Fox Chase Cancer Center, Philadelphia
Istituto Europeo di Oncologia s.r.l, Milan
Trakya Univ. Tip Fak., Edirne
Inova Schar Cancer Institute, Fairfax
Hopital Jean Minjoz, Besançon
West Virginia University, Morgantown
Wake Forest Baptist Health, Winston-Salem
UNC Hospitals - UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Fundacion Jimenez Diaz (Clinica de la Concepcion), Madrid
Centro Integral Oncológico Clara Campal, Madrid
Institut Bergonie - Unicancer Nouvelle Aquitaine - Service Oncologie medicale, Bordeaux
Memorial Cancer Institute at West, Pembroke Pines
A.S.U. Friuli Centrale - A. Regionale Coordinamento Salute, Udine
Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul
Istanbul Universitesi Cerrahpasa-Cerrahpasa Tip Fakultesi, Istanbul
TC Saglik Bakanligi Goztepe ProfDr Suleyman Yalcin Sehir Has, Istanbul
Istituto Oncologico Veneto, Padua
Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma, Izmir
Vanderbilt University Medical Center, Nashville
Erciyes Universitesi Tip Fakultesi, Kayseri
A.O.U. di Bologna Policlinico S.Orsola Malpighi, Bologna
Cleveland Clinic - Neurology, Cleveland
Institut de Cancerologie Ouest - Saint-Herblain, Saint-Herblain
Avera Cancer Institute - Sioux Falls, Sioux Falls
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology, Chicago
ICANS - Institut de Cancerologie de Strasbourg Europe - service oncologie medicale, Strasbourg
Hopital Saint Antoine APHP - Departement Oncologie, Paris
APHP-Hopital la Pitie Salpetriere-Departement oncologie, Paris
The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Fakultní Nemocnice Olomouc, Olomouc
A.O.R.N. San Giuseppe Moscati, Avellino
Hôpital de la Milétrie, Poitiers
UCLA Health Santa Monica Cancer Care, Santa Monica
Stanford Cancer Center Palo Alto, Palo Alto
Beijing Cancer Hospital - Oncology Department, Beijing
Instituto Nacional de Cancerología INC Colombia, Bogota
Russian Oncological Scientific Center n.a. N.N. Blokhin RAMS, Moscow
1st Moscow State Medical University n.a. I.M.Sechenov, Moscow
Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk
National Cancer Center Singapore - Oncology Department, Singapore
St. Petersburg Clinical Onc. Cent. of Spec. Types of Care, Saint Petersburg
Zhongshan Hospital, Fudan University - Oncology Department, Shanghai
Oncomédica S.A., Montería
Republican Clinical Oncology Dispensary Kazan, Kazan'
Sun Yat-sen University Cancer Center, Guangzhou
Clinical Diagnostical Center, Nizhny Novgorod
Jawaharlal Institute Of Postgraduate Medical Education and R, Gorimedu
Fundación Oftalmológica de Santander Carlos Ardila Lule, Floridablanca
All India Institute of Medical Sciences, Bhubaneswar
Mass General Cancer Center, Boston
Dana-Farber Cancer Institute - Oncology Department, Boston
Hospital Alemán, Buenos Aires
"Centro Estudios Médicos e Invest. Clínicas Dr. N. Quirno", Buenos Aires
St Vincents University Hospital, Dublin
Fundación Cenit para la Investigación en Neurociencias, CABA
Centro Medico Austral, TBC
Centro Médico San Roque, San Miguel de Tucumán
Hosp. Araujo Jorge da Associação de Combate ao Câncer, Goiânia
Cenantron Centro Avançado de Tratamento Oncológico, Ltda., Belo Horizonte
Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos/SP
Instituto do Cancer do Estado de Sao Paulo, São Paulo
Real e Benemérita Associação Portuguesa de Beneficência, São Paulo
IBCC - Instituto Brasileiro de Controle do Cancer, São Paulo
Instituto Nacional do Câncer - INCA - HC II, Rio de Janeiro
INCA - Hospital do Cancer III, Rio de Janeiro
Oncoclínicas Rio de Janeiro S.A, Rio de Janeiro
Hospital Sirio Libanes, São Paulo
Tom Baker Cancer Centre, Calgary
Sichuan University West China Hospital, Chengdu
Centre Antoine Lacassagne - Departement Oncologie, Nice
Nagoya University Hospital, Nagoya
National Cancer Center Hospital East, Kashiwa
Hokkaido University Hospital, Sapporo
The Cancer Institute Hospital of JFCR, Koto-ku
IPO Porto, Porto
Onkologicky Ustav Svatej Alzbety, s.r.o., Bratislava
Narodny onkologicky ustav, Bratislava
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center - Oncology Department, Seoul
Samsung Medical Center - Oncology Department, Seoul
Hospital del Mar, Barcelona
Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona
"Hospital General Universitario Gregorio Maranon , Oncologia"
Karolinska Universitetssjukhuset Solna - Tema Cancer, Stockholm
Lead Sponsor
Bayer
INDUSTRY